102 However, various groups are advocating for your incorporation of novel markers, such as a sophisticated karyotype55 or epigenetic subsets, 27,28 into clinical follow. These novel prognostic and/or predictive designs will have to be validated in cohorts of sufferers dealt with with specific agents. Tidak ada cara yang lebih baik https://marlonu122cys8.loginblogin.com/profile